Cargando…
Immune rebalancing : the future of immunosuppression /
Immune Rebalancing: The Future of Immunosuppression summarizes the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression by considering molecular pathways, personalized medicine, microbiome and nanomedicine. Modulation of immune responses for therapeutic p...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London Wall [UK] :
Academic Press is an imprint of Elsevier,
2016.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Immune Rebalancing; Copyright Page; Contents; List of Contributors; 1 Pharmacological Strategies Using Biologics as Immunomodulatory Agents; 1.1 Introduction; 1.2 From Nonspecific to Targeted Immunosuppression; 1.3 From Immunosuppression to Immune Rebalancing; 1.4 Conclusions; Acknowledgments; References; I. Mechanisms of Immune-Related Pathologies and their Current Treatment; 2 Advance in Therapies for Rheumatoid Arthritis: New Perspectives; 2.1 Introduction; 2.2 Rheumatoid Arthritis Management; 2.2.1 Glucococorticoids; 2.2.2 Methotrexate; 2.2.3 Leflunomide; 2.2.4 Sulfasalazine.
- 2.2.5 Cyclosporin A2.2.6 Azathioprine; 2.2.7 Cyclophosphamide; 2.2.8 Antimalarials; 2.2.9 Biologics; 2.2.10 Tumor Necrosis Factor Inhibitors; 2.2.11 T-Lymphocyte Costimulation Blocker: Abatacept; 2.2.12 Anti-B-Cell Therapy: Rituximab; 2.2.13 Anakinra; 2.2.14 Tocilizumab; 2.2.15 Protein Kinase Inhibitors; 2.3 New Alternatives for the Treatment of RA; 2.4 Loss of Immune Tolerance as a Factor for RA Development: A Possible Target; 2.5 Resolution of Inflammation; 2.5.1 Lipid Mediators; 2.5.2 Annexin A1; 2.6 Challenges; 2.7 Concluding Remarks; References.